MAI Capital Management
PRME icon

MAI Capital Management’s Prime Medicine PRME Stock Holding History

MAI Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-386
Closed -$1.34K – 4042
2026
Q1 		$1.34K Buy
386
+112
+41% +$426 ﹤0.01% 4078
2025
Q4 		$951 Hold
274
– – ﹤0.01% 3643
2025
Q3 		$1.52K Sell
274
-341
-55% -$1.39K ﹤0.01% 3379
2025
Q2 		$1.52K Buy
+615
New +$948 ﹤0.01% 3498

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

MAI Capital Management's PRME Position: Q2 2026 in Review

MAI Capital Management sold out of Prime Medicine (PRME) in Q2 2026, closing a stake of 386 shares — an estimated $1.34K sold.

MAI Capital Management first reported a position in PRME in Q2 2025 and held it in 4 quarters. The position peaked at $1.52K in Q2 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • MAI Capital Management reported no remaining Prime Medicine position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 386 Prime Medicine shares in Q2 2026, an estimated $1.34K.
  • MAI Capital Management first reported a position in Prime Medicine in Q2 2025 and held it in 4 quarters.
  • MAI Capital Management's Prime Medicine position peaked at $1.52K in Q2 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.